Troponin in critical care patients and outcomes
Elizabeth M Cole1, Annemarie B Docherty2
1Department of Anaesthesia, NHS Lothian, Edinburgh, UK.
Insights
Critically ill patients with cardiovascular disease often experience unrecognized myocardial infarction, leading to higher mortality. Early identification and management of oxygen supply-demand imbalance can improve outcomes.
Area of Science:
- Critical Care Medicine
- Cardiology
- Biomarkers
Background:
- Myocardial infarction (MI) is a frequent complication in critically unwell patients, particularly those with pre-existing cardiovascular disease.
- MI in this population is linked to significantly increased overall mortality.
- A substantial number of intensive care unit (ICU) patients with acute MI remain undiagnosed.
Purpose of the Study:
- To explore current guidelines for diagnosing myocardial infarction in critically ill patients.
- To review research on the utility of troponin as a diagnostic and prognostic marker.
- To highlight the potential for improved patient outcomes through risk identification and care modification.
Main Methods:
- Review of existing clinical guidelines for MI diagnosis.
- Analysis of research studies investigating troponin's role in diagnosis and prognosis.
- Discussion of the pathophysiology of MI in the critically unwell, focusing on oxygen supply-demand imbalance.
Main Results:
- The majority of acute myocardial infarctions in the ICU setting are currently unrecognized.
- Oxygen supply-demand imbalance is the predominant underlying cause of MI in this cohort.
- Troponin assays are valuable diagnostic and prognostic tools.
Conclusions:
- Improved recognition of myocardial infarction in critically ill patients is crucial.
- Addressing oxygen supply-demand imbalance offers a potential strategy to reduce mortality.
- Utilizing troponin effectively can aid in both diagnosis and prognosis, leading to better patient management.
Abstract:
Myocardial infarction is common in the critically unwell population with pre-existing cardiovascular disease and is associated with a greater overall mortality. This article explores guidelines for diagnosing myocardial infarction, and research into the use of troponin as both a diagnostic and prognostic tool. Currently, the majority of patients in the intensive care unit with acute myocardial infarction go unrecognised. The underlying cause is predominantly oxygen supply-demand imbalance, therefore identifying those at risk is important as there is the potential to modify elements of their care and reduce their overall mortality.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome IV: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
